Percheron Therapeutics's total assets for Q4 2025 were AU$12.44M, a decrease of -30.61% from the previous quarter. AU:PER total liabilities were AU$2.43M for the fiscal quarter, a -7.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.